Image
Read our key takeaways from the 2022 ASAS-EULAR recommendations for the management of axSpA, presented as part of Dr Sofia Ramiro's workshop at UCB Summit 2023.
Back to top
Prof Thrasyvoulos Tzellos
Dermatologist
Professor Thrasyvoulos Tzellos is Dermatologist at the Department of Dermatology, NLSH Bodø, Norway, and Associate Professor at Institute of Clinical Medicine, University of Tromsø, Norway.
Professor Tzellos received his medical degree from the Aristotle University of Thessaloniki, Greece, moving on to complete an MSc in Clinical Research and Epidemiology and a PhD from the same institution. He has also completed several postgraduate courses on educational techniques, epidemiology and clinical pharmacology in healthcare.
He has published over 100 peer-reviewed articles and his current research expertise lies in the field of evidence-based medicine, clinical trials, meta-analyses, case-control studies, cohort studies and large-scale epidemiological studies. He is actively involved in clinical research on hidradenitis suppurativa and is a founding member of the European Hidradenitis Suppurativa Foundation (EHSF).
0 resources
Video1 minute watch
Watch Prof Robert Landewé discuss the importance of using ASDAS <2.1 as a treatment target for patients with axSpA.
EU-DA-2400662
Article3 minutes read
EU-DA-2400660
Video2 minutes watch
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss the role of the IL-17 family of cytokines in SpA pathobiology.
EU-DA-2400654
Video21 minutes watch
Join Prof Dennis McGonagle and Prof Lars Erik Kristensen in unraveling the role of the IL-17 family in the pathogenic inflammation and manifestations of SpA in...
EU-DA-2400657
Video4 minutes watch
Play the animation to accompany Assoc. Prof Philipp Sewerin in deciphering the role of extracellular cytokine targets in SpA pathobiology.
EU-DA-2400656
File
From practical tips to strategies that help support your patients' emotional well-being, find out how you can help your patients make positive changes
EU-DA-2400181